Study details
Enrolling now
Impact of Early Aging and Menopause on Vascular Responses to Hypoxia
University of Missouri-Columbia
NCT IDNCT06417177ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
75
Study length
about 2.2 years
Ages
18–70
Sex
Female only
Locations
1 site in MO
What this study is about
Researchers are testing how aging, menopause, and hypoxia affect blood vessels. The trial will evaluate the role of beta-adrenergic receptors in women experiencing these conditions. Participants will receive either Gemtesa, a placebo, or Propranolol.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Gemtesa
- 2.Take Placebo
- 3.Take Propranolol
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
propranolol (Non-selective beta blocker; slows heart rate)
Body systems
Reproductive Health